Quick Answer
Vitamin D Strength Meta-Analysis has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: 1 2 3 4 Sarcopenia is a condition characterized by the progressive and generalized loss of muscle mass and function that primarily affects the older adult population, compromising their autonomy and quality of life, as it associated with a significantly increased risk of falls, hospitalizations, and mortality ().
Key Takeaways
- 011 2 3 4 Sarcopenia is a condition characterized by the progressive and generalized loss of muscle mass and function that primarily affects the older adult population, compromising their autonomy and quality of life, as it associated with a significantly increased risk of falls, hospitalizations, and mortality (). [Calderón Paula (2026)]
- 02One of the cornerstones of the prevention and treatment of sarcopenia is a protein-rich diet; however, current evidence suggests that standard protein intake recommendations may be insufficient to overcome the “anabolic resistance” characteristic of advanced age (,). [Calderón Paula (2026)]
- 03The main molecular mechanisms, mediated by NF- κB, mTOR, and TGF- β, involved in cellular senescence are associated with the activation of transcriptional programs that regulate gene expression, signaling pathways, and metabolism regulators, developing a senescence-associated secretory phenotype (SASP) (,). [Calderón Paula (2026)]
- 04This is due to age-related mechanisms of cellular senescence, oxidative stress, and low-grade chronic inflammation, all factors that exacerbate muscle catabolism and limit the regenerative capacity of the muscle tissue during aging (). [Calderón Paula (2026)]
The current Migaku evidence database contains 2 reusable source documents for Vitamin D Strength Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts.
- 1 2 3 4 Sarcopenia is a condition characterized by the progressive and generalized loss of muscle mass and function that primarily affects the older adult population, compromising their autonomy and quality of life, as it associated with a significantly increased risk of falls, hospitalizations, and mortality (). [Calderón Paula (2026); evidence level 3]
- One of the cornerstones of the prevention and treatment of sarcopenia is a protein-rich diet; however, current evidence suggests that standard protein intake recommendations may be insufficient to overcome the “anabolic resistance” characteristic of advanced age (,). [Calderón Paula (2026); evidence level 3]
- The main molecular mechanisms, mediated by NF- κB, mTOR, and TGF- β, involved in cellular senescence are associated with the activation of transcriptional programs that regulate gene expression, signaling pathways, and metabolism regulators, developing a senescence-associated secretory phenotype (SASP) (,). [Calderón Paula (2026); evidence level 3]
- This is due to age-related mechanisms of cellular senescence, oxidative stress, and low-grade chronic inflammation, all factors that exacerbate muscle catabolism and limit the regenerative capacity of the muscle tissue during aging (). [Calderón Paula (2026); evidence level 3]
- This emerging area highlights how genetic differences shape vitamin D absorption, metabolism, transport, and cellular action, ultimately influencing disease risk and health outcomes. [Qahtan Fatima (2026); evidence level 3]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources